Immune-based therapies: an adjunct to antiretroviral treatment (Q36223885)

12 August 2017

1 reference

title

Immune-based therapies: an adjunct to antiretroviral treatment (English)

1 reference

12 August 2017

anti-retroviral agent

0 references

author name string

Jeffrey M Jacobson

series ordinal

1

1 reference

12 August 2017

1 June 2005

1 reference

12 August 2017

Current HIV/AIDS reports

1 reference

12 August 2017

2

1 reference

12 August 2017

2

1 reference

12 August 2017

90-97

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-005-0024-4

12 August 2017

0 references

cites work

Placebo-controlled trial of cyclosporin-A in HIV-1 disease: implications for solid organ transplantation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11904-005-0024-4

Changes in thymic function with age and during the treatment of HIV infection

21 January 2018

1 reference

12 December 2020

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

12 December 2020

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

1 reference

12 December 2020

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

1 reference

12 December 2020

Early reduction of immune activation in lymphoid tissue following highly active HIV therapy

1 reference

12 December 2020

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

1 reference

12 December 2020

Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone.

1 reference

12 December 2020

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

1 reference

12 December 2020

Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy

1 reference

12 December 2020

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

12 December 2020

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

12 December 2020

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

12 December 2020

Cytokine therapies in HIV-1 infection: present and future

1 reference

12 December 2020

IL-15 in the life and death of lymphocytes: immunotherapeutic implications

1 reference

12 December 2020

Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

1 reference

12 December 2020

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

1 reference

12 December 2020

Effects of growth hormone and insulin-like growth factor I on the immune system

1 reference

12 December 2020

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

12 December 2020

Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy

1 reference

12 December 2020

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

1 reference

12 December 2020

Interleukin-7: master regulator of peripheral T-cell homeostasis?

1 reference

12 December 2020

Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection

1 reference

12 December 2020

The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy

1 reference

12 December 2020

Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression

1 reference

12 December 2020

Can HIV be Cured? Mechanisms of HIV persistence and strategies to combat it.

1 reference

12 December 2020

Viral persistence: HIV's strategies of immune system evasion

1 reference

12 December 2020

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

1 reference

12 December 2020

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

12 December 2020

Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons.

1 reference

12 December 2020

Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb

1 reference

12 December 2020

Immunoliposomes containing antibodies to costimulatory molecules as adjuvants for HIV subunit vaccines

1 reference

12 December 2020

Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy

1 reference

12 December 2020

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).

1 reference

12 December 2020

Nadir CD4+ T Cell Count Predicts Response to Subcutaneous Recombinant Interleukin-2

1 reference

12 December 2020

The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of < or = 50 x 10(6) cells/l

1 reference

12 December 2020

Generation and maintenance of immunological memory

1 reference

12 December 2020

Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients.

1 reference

12 December 2020

Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression

1 reference

12 December 2020

Protection by live, attenuated simian immunodeficiency virus against heterologous challenge.

1 reference

12 December 2020

IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates

1 reference

12 December 2020

In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months

1 reference

12 December 2020

Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen

1 reference

12 December 2020

Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection

1 reference

12 December 2020

HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus

1 reference

12 December 2020

Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden

1 reference

12 December 2020

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

1 reference

12 December 2020

Growth hormone in T-lymphocyte thymic and postthymic development: a study in HIV-infected children

1 reference

12 December 2020

Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation

1 reference

12 December 2020

The Effects of Different HIV Type 1 Strains on Human Thymic Function

1 reference

12 December 2020

Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study--ANRS 082.

1 reference

12 December 2020

Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease

1 reference

12 December 2020

Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.

1 reference

12 December 2020

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

12 December 2020

A potential role for interleukin-7 in T-cell homeostasis

1 reference

12 December 2020

Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection

1 reference

12 December 2020

Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis

1 reference

12 December 2020

A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3).

1 reference

12 December 2020

Placebo-controlled trial of prednisone in advanced HIV-1 infection

1 reference

12 December 2020

Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy

1 reference

12 December 2020

Prevention of HIV infection by passive immunization with HIV immunoglobulin

1 reference

12 December 2020

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

12 December 2020

10.1007/S11904-005-0024-4

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16091254